Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

236.72
+5.552.40%
Pre-market: 236.720.00000.00%04:00 EDT
Volume:3K
Turnover:756.09K
Market Cap:474.98M
PE:- -
High:236.72
Open:236.01
Low:235.52
Close:231.17
52wk High:244.35
52wk Low:160.91
Shares:2.01M
Float Shares:2.01M
Volume Ratio:0.74
T/O Rate:0.16%
Dividend:0.95
Dividend Rate:0.40%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS
·
Sep 14

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS
·
Sep 14

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS
·
Sep 14

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 14

Vertex Minerals Revises Timeline for Proposed Securities Issue

TIPRANKS
·
Sep 14

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)

TIPRANKS
·
Sep 14

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

TIPRANKS
·
Sep 12

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

Regeneron and Sanofi Complete Key Dupilumab Itch Study, Expanding Dermatology Upside

TIPRANKS
·
Sep 12

Political and General News Events from September 11

Reuters
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Revolution Medicines Director Lorence H. Kim Disposes of 17,090 Common Shares Worth USD 3.57 Million

Reuters
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

Dow Jones
·
Sep 11

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

TIPRANKS
·
Sep 11

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live
·
Sep 10

Dow's 300-Point Drop Led by Losses in Shares of Nvidia Corp., Amgen

Dow Jones
·
Sep 10